New treatments for metastatic melanoma

Por Gedye, Craig, Hogg, David, Butler, Marcus, Joshua, Anthony M.
Publicado em 2014

Renal cell carcinoma bone metastases: clinical advances

Por Sahi, Chakshu, Knox, Jennifer J., Clemons, Mark, Joshua, Anthony M., Broom, Reuben
Publicado em 2010

Retinal vasculitis and ocular vitreous metastasis following complete response to PD-1 inhibition in a patient with metastatic cutaneous melanoma

Por Manusow, Joshua S, Khoja, Leila, Pesin, Nataly, Joshua, Anthony M, Mandelcorn, Efrem D
Publicado no J Immunother Cancer (2014)

Pembrolizumab

Por Khoja, Leila, Butler, Marcus O., Kang, S. Peter, Ebbinghaus, Scot, Joshua, Anthony M.
Publicado no J Immunother Cancer (2015)

Increased treatment-related toxicity subsequent to an anti–PD-1 agent

Por Khoja, Leila, Butler, Marcus Ortho, Chappell, Mary Anne, Hogg, David, Joshua, Anthony M.
Publicado no Curr Oncol (2015)

Assessment of a prognostic model, PSA metrics and toxicities in metastatic castrate resistant prostate cancer using data from Project Data Sphere (PDS)

Por Pitcher, Bethany, Khoja, Leila, Hamilton, Robert J., Abdallah, Kald, Pintilie, Melania, Joshua, Anthony M.
Publicado no PLoS One (2017)

Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study

Por Niraula, Saroj, Pond, Greg, de Wit, Ronald, Eisenberger, Mario, Tannock, Ian F., Joshua, Anthony M.
Publicado em 2013

Real-world efficacy, toxicity and clinical management of ipilimumab treatment in metastatic melanoma

Por KHOJA, LEILA, ATENAFU, ESHETU G., YE, QIAN, GEDYE, CRAIG, CHAPPELL, MARYANNE, HOGG, DAVID, BUTLER, MARCUS O., JOSHUA, ANTHONY M.
Publicado no Oncol Lett (2016)

Patterns of response to anti-PD-1 treatment: an exploratory comparison of four radiological response criteria and associations with overall survival in metastatic melanoma patients

Por Khoja, Leila, Kibiro, Minnie, Metser, Ur, Gedye, Craig, Hogg, David, Butler, Marcus O, Atenafu, Eshetu G, Joshua, Anthony M
Publicado no Br J Cancer (2016)

Three-Color FISH Analysis of TMPRSS2/ERG Fusions in Prostate Cancer Indicates That Genomic Microdeletion of Chromosome 21 Is Associated with Rearrangement

Por Yoshimoto, Maisa, Joshua, Anthony M., Chilton-MacNeill, Susan, Bayani, Jane, Selvarajah, Shamini, Evans, Andrew J., Zielenska, Maria, Squire, Jeremy A.
Publicado em 2006

A Phase 2 Study of GW786034 (Pazopanib) with or without Bicalutamide in Patients with Castration Resistant Prostate Cancer

Por Sridhar, Srikala S., Joshua, Anthony M., Gregg, Richard, Booth, Christopher M., Murray, Nevin, Golubovic, Jovana, Wang, Lisa, Harris, Pamela, Chi, Kim N.
Publicado no Clin Genitourin Cancer (2014)

The full blood count as a biomarker of outcome and toxicity in ipilimumab‐treated cutaneous metastatic melanoma

Por Khoja, Leila, Atenafu, Eshetu G., Templeton, Arnoud, Qye, Ye, Chappell, Mary Anne, Saibil, Sam, Hogg, David, Butler, Marcus O., Joshua, Anthony M.
Publicado no Cancer Med (2016)

Changes in plasma biomarkers following treatment with cabozantinib in metastatic castration-resistant prostate cancer: a post hoc analysis of an extension cohort of a phase II tria...

Por Leibowitz-Amit, Raya, Pintilie, Melania, Khoja, Leila, Azad, Arun A., Berger, Raanan, Laird, A. Douglas, Aftab, Dana T., Chi, Kim N., Joshua, Anthony M.
Publicado no J Transl Med (2016)

PTEN Deletion in Prostate Cancer Cells Does Not Associate With Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy

Por Fraser, Michael, Zhao, Helen, Luoto, Kaisa R., Lundin, Cecilia, Coackley, Carla, Chan, Norman, Joshua, Anthony M., Bismar, Tarek A., Evans, Andrew, Helleday, Thomas, Bristow, Robert G.
Publicado em 2011

Effects of THBS3, SPARC and SPP1 expression on biological behavior and survival in patients with osteosarcoma

Por Dalla-Torre, Cristiane A, Yoshimoto, Maisa, Lee, Chung-Hae, Joshua, Anthony M, de Toledo, Silvia RC, Petrilli, Antônio S, Andrade, Joyce AD, Chilton-MacNeill, Susan, Zielenska, Maria, Squire, Jeremy A
Publicado em 2006

Chemotherapy treatment decision-making experiences of older adults with cancer, their family members, oncologists and family physicians: a mixed methods study

Por Puts, Martine T. E., Sattar, Schroder, McWatters, Kara, Lee, Katherine, Kulik, Michael, MacDonald, Mary-Ellen, Jang, Raymond, Amir, Eitan, Krzyzanowska, Monika K., Leighl, Natasha, Fitch, Margaret, Joshua, Anthony M., Warde, Padraig, Tourangeau, Ann E., Alibhai, Shabbir M. H.
Publicado no Support Care Cancer (2016)

Safety of enzalutamide in patients with metastatic castration‐resistant prostate cancer previously treated with docetaxel: Expanded access in North America

Por Joshua, Anthony M., Shore, Neal D., Saad, Fred, Chi, Kim N., Olsson, Carl A., Emmenegger, Urban, Scholz, Mark, Berry, William, Mukherjee, Som D., Winquist, Eric, Haas, Naomi B., Foley, Margaret A., Dmuchowski, Carl, Perabo, Frank, Hirmand, Mohammad, Hasabou, Nahla, Rathkopf, Dana
Publicado no Prostate (2015)

Expansion and Characterization of Human Melanoma Tumor-Infiltrating Lymphocytes (TILs)

Por Nguyen, Linh T., Yen, Pei Hua, Nie, Jessica, Liadis, Nicole, Ghazarian, Danny, Al-Habeeb, Ayman, Easson, Alexandra, Leong, Wey, Lipa, Joan, McCready, David, Reedijk, Michael, Hogg, David, Joshua, Anthony M., Quirt, Ian, Messner, Hans, Shaw, Patricia, Crump, Michael, Sharon, Eran, Ohashi, Pamela S.
Publicado em 2010

Development of an adoptive cell therapy protocol with tumor-infiltrating lymphocytes and intermediate-dose interleukin-2 therapy

Por Nguyen, Linh T, Butler, Marcus O, Yen, Pei Hua, Nie, Jessica, Pniak, Michael, Elford, Alisha R, Joshua, Anthony M, Hogg, David, Ghazarian, Danny, Al-Habeeb, Ayman, Easson, Alexandra M, Leong, Wey L, McCready, David R, Reedijk, Michael, Messner, Hans A, Ohashi, Pamela S
Publicado em 2013

Improvements in Radiographic Progression-Free Survival Stratified by ERG Gene Status in Castration-Resistant Prostate Cancer Patients Treated with Abiraterone

Por Attard, Gerhardt, de Bono, Johann S., Logothetis, Christopher J., Fizazi, Karim, Mukherjee, Som D., Joshua, Anthony M., Schrijvers, Dirk, van den Eertwegh, Alfons J.M., Li, Weimin, Molina, Arturo, Griffin, Thomas W., Kheoh, Thian, Ricci, Deborah S., Zelinsky, Kathy, Rathkopf, Dana E., Scher, Howard I., Ryan, Charles J.
Publicado no Clin Cancer Res (2015)